B 2011

Obecná onkologie

ADAM, Zdeněk, Marta KREJČÍ, Jiří VORLÍČEK, Zuzana ADAMOVÁ, Jaroslav BAČOVSKÝ et. al.

Basic information

Original name

Obecná onkologie

Name (in English)

General oncology

Authors

ADAM, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), Marta KREJČÍ (203 Czech Republic, belonging to the institution), Jiří VORLÍČEK (203 Czech Republic, belonging to the institution), Zuzana ADAMOVÁ (203 Czech Republic), Jaroslav BAČOVSKÝ (203 Czech Republic), Viera BAJČIOVÁ (703 Slovakia, belonging to the institution), Otakar BEDNAŘÍK (203 Czech Republic, belonging to the institution), Jan BLATNÝ (203 Czech Republic, belonging to the institution), Tomáš BÜCHLER (203 Czech Republic), Igor CRHA (203 Czech Republic, belonging to the institution), Aleš ČERMÁK (203 Czech Republic, belonging to the institution), Hana DOLEŽELOVÁ (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Karel DVOŘÁK (203 Czech Republic, belonging to the institution), Pavel FABIAN (203 Czech Republic), Vuk FAIT (203 Czech Republic, belonging to the institution), Antonín FASSMANN (203 Czech Republic, belonging to the institution), Jindřich FIALA (203 Czech Republic, belonging to the institution), Lukáš FIALA (203 Czech Republic), Jindřich FÍNEK (203 Czech Republic), Lenka FORETOVÁ (203 Czech Republic, belonging to the institution), Radim GROSMAN (203 Czech Republic, belonging to the institution), Jana HALÁMKOVÁ (203 Czech Republic, belonging to the institution), Miroslav HEŘMAN (203 Czech Republic), Martin HUSER (203 Czech Republic, belonging to the institution), Ludmila HYNKOVÁ (203 Czech Republic, belonging to the institution), Richard CHALOUPKA (203 Czech Republic, belonging to the institution), Libuše KALVODOVÁ (203 Czech Republic, belonging to the institution), Igor KISS (203 Czech Republic, belonging to the institution), Iva KOCMANOVÁ (203 Czech Republic, belonging to the institution), Martin KOMENDA (203 Czech Republic, belonging to the institution), Jana KOPTÍKOVÁ (203 Czech Republic, belonging to the institution), Zdeněk KOŘÍSTEK (203 Czech Republic, belonging to the institution), Renata KOUKALOVÁ (203 Czech Republic), Zdeněk KRÁL (203 Czech Republic, belonging to the institution), Eva LÉTALOVÁ (203 Czech Republic, belonging to the institution), Milan MACHÁLKA (203 Czech Republic, belonging to the institution), Josef MALIŠ (203 Czech Republic), Miloslava MATÝŠKOVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution), Vojtěch MORNSTEIN (203 Czech Republic, belonging to the institution), Mojmír MOULIS (203 Czech Republic, belonging to the institution), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Miroslav MYSLIVEČEK (203 Czech Republic), Milan NAVRÁTIL (203 Czech Republic), Tomáš NEBESKÝ (203 Czech Republic), Miroslav NEČAS (203 Czech Republic, belonging to the institution), Rudolf NENUTIL (203 Czech Republic, belonging to the institution), Jiří NEUBAUER (203 Czech Republic, belonging to the institution), Martin ONDRÁK (203 Czech Republic), Zdeněk PAVELKA (203 Czech Republic, belonging to the institution), Miroslav PENKA (203 Czech Republic, belonging to the institution), Vojtěch PEŘINA (203 Czech Republic, belonging to the institution), Katarína PETRÁKOVÁ (203 Czech Republic, belonging to the institution), Petr POKORNÝ (203 Czech Republic), Luděk POUR (203 Czech Republic, belonging to the institution), Jiří PRÁŠEK (203 Czech Republic, belonging to the institution), Zdeněk RÁČIL (203 Czech Republic, belonging to the institution), Martin REPKO (203 Czech Republic, belonging to the institution), Zdeněk ŘEHÁK (203 Czech Republic), Jiří SCHOVANEC (203 Czech Republic), Ondřej SLÁMA (203 Czech Republic, belonging to the institution), Petr SMÍŠEK (203 Czech Republic), Jan STARÝ (203 Czech Republic), Petr SZTURZ (203 Czech Republic, belonging to the institution), Marek SVOBODA (203 Czech Republic, belonging to the institution), Vlastimil ŠČUDLA (203 Czech Republic), Roman ŠEFR (203 Czech Republic), Pavel ŠEVČÍK (203 Czech Republic, belonging to the institution), Pavel ŠLAMPA (203 Czech Republic, belonging to the institution), Lenka ŠMARDOVÁ (203 Czech Republic, belonging to the institution), Jiří ŠNAJDAUF (203 Czech Republic), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution), Michal TICHÝ (203 Czech Republic), Jiří TOMÁŠEK (203 Czech Republic, belonging to the institution), Miroslav TOMIŠKA (203 Czech Republic, belonging to the institution), Marcela TOMÍŠKOVÁ (203 Czech Republic, belonging to the institution), Vít UNZEITIG (203 Czech Republic, belonging to the institution), Jiří VANÍČEK (203 Czech Republic, belonging to the institution), Vladimír VAŠKŮ (203 Czech Republic, belonging to the institution), Rostislav VYZULA (203 Czech Republic, belonging to the institution), Barbora WEINBERGEROVÁ (203 Czech Republic), Marie ZÍTKOVÁ (203 Czech Republic) and Karel ZITTERBART (203 Czech Republic, belonging to the institution)

Edition

První vydání. Praha, 394 pp. 2011

Publisher

Galén

Other information

Language

Czech

Type of outcome

Odborná kniha

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

References:

RIV identification code

RIV/00216224:14110/11:00049711

Organization unit

Faculty of Medicine

ISBN

978-80-7262-715-8

Keywords (in Czech)

onkologie; onkopatologie; diagnostika; léčba;

Keywords in English

oncology; oncopathology; treatment
Změněno: 12/7/2014 20:00, doc. MUDr. et MUDr. Vojtěch Peřina, Ph.D.

Abstract

V originále

Kniha obsahuje obecně zaměřené kapitoly o etiologických faktorech a možnostech prevence maligních onemocnění. Je psána tak, aby v ní každý lékař, který se ve své praxi setkává s pacienty s onkologickým onemocněním, mohl najít užitečné informace pro svoji každodenní práci. Podrobně zpracovaná kapitola o systémových a paraneoplastických projevech nádorových nemocí by měla přispět k časnému rozpoznání zhoubného nádoru. Další kapitoly se zabývají jednotlivými léčebnými alternativami. Následují kapitoly, jejichž cílem je předložit čtenáři informace, jak zvládat komplikace, které s sebou tyto nemoci přinášejí - například chronickou bolest, infekce, nádorem způsobené výpotky, metabolické komplikace a problémy s výživou i s fertilitou, ale také psychické problémy. Součástí knihy je CD.

In English

The book contains generic chapters on etiological factors and possible prevention of malignant disease:the systemic and paraneoplastic manifestations of malignant disease, treatment options, complications - such as chronic pain, infection, tumors caused by effusion, metabolic complications and nutritional problems with fertility, but also psychological problems.

Links

GAP304/10/1395, research and development project
Name: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation
LC06027, research and development project
Name: Univerzitní výzkumné centrum - Česká myelomová skupina (Acronym: LC MGUS)
Investor: Ministry of Education, Youth and Sports of the CR, University Research Centre - Czech Myeloma Group
MSM0021622434, plan (intention)
Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
MUNI/A/1012/2009, interní kód MU
Name: Optimalizace diagnostiky a terapie maligních chorob a komplikací, které tyto maligní nemoci provázejí, s využitím nových molekulárně biologických metod.
Investor: Masaryk University, Category A
NS10207, research and development project
Name: Úloha abnormalit chromozómu 1 a kaskády NF-kappaB v patogenezi mnohočetného myelomu
Investor: Ministry of Health of the CR
NS10406, research and development project
Name: Vytvoření prognostického panelu u pacientů s monoklonální gamapatií nejasného významu s cílem zabránění transformace v maligní onemocnění.
Investor: Ministry of Health of the CR